Dépôt DSpace/Manakin

Vaccination et vaccins anti COVID-19

Afficher la notice abrégée

dc.contributor.author MABUNGU NDOMBE, Jonathan
dc.date.accessioned 2021-11-22T07:59:46Z
dc.date.available 2021-11-22T07:59:46Z
dc.date.issued 2021
dc.identifier.uri http://e-biblio.univ-mosta.dz/handle/123456789/19591
dc.description.abstract Vaccination is one of the main means to fight infectious diseases and it is nowadays a real public health issue since it saves millions of lives around the world. It plays a major role in modern medicine, because thanks to its mallpox has been eradicated and some any other epidemics have been broughtunder control. Currently, the whole world is facing coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The death rate has prompted scientists to develop safe and effective vaccines to prevent the spread of the disease. Vaccines are the main intervention strategy in controlling the transmission of coronaviruses.In this context, various strategies have been developed for the manufacture of vaccines. Following the discovery of the Spike protein, several types of COVID-19 vaccines have developed such as : inactivated vaccines, nucleicacid (mRNA) vaccines, adenovirus vaccines, vector vaccines and recombinant subunit vaccines. So many other strategies are underdevelopment. In fact, more than 200 candidates vaccines are beingdeveloped, including more than 60 in the clinical trial phase. en_US
dc.language.iso fr en_US
dc.subject Keywords : vaccination, vaccine, SARS-Cov-2, Spike protein en_US
dc.title Vaccination et vaccins anti COVID-19 en_US
dc.type Other en_US


Fichier(s) constituant ce document

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Chercher dans le dépôt


Parcourir

Mon compte